Chief Business Officer
Kent BioEnergy Corporation
Barry Toyonaga, Ph.D., Chief Business Officer, Kent BioEnergy Corporation, is responsible for the global strategic partnering of the company's bio-fuel and renewable technology assets. He has over 20 years of international experience in the diverse activities related to capital formation for technology-rich companies.
He was a partner at Ventana Capital (San Juan Capistrano, CA) and held executive/management positions in early-stage and established biotechnology companies, as well as within various divisions of Johnson & Johnson.
As the founder and president of Ontogen Corporation, a pioneer in the field of automated synthetic chemistry, he closed equity financings ($30MM), realized strategic alliance revenues ($50MM), grew the company to over 100 employees, and moved an in-house discovery successfully through Phase I clinical trials.
Dr. Toyonaga was a Visiting Research Scientist at The Scripps Research Institute (La Jolla, CA), the California Institute of Technology (Pasadena, CA), and Yale University (New Haven, CT). He was also a MRC postdoctoral fellow at the Ontario Cancer Institute (Toronto, ON) and involved in the discovery of the human T Cell Receptor. He received a Ph.D. in physical organic chemistry from the University of Toronto (St. George Campus, Toronto, ON).